141 related articles for article (PubMed ID: 35733000)
1. Application of Transcription Factor Decoy Oligodeoxynucleotides (ODNs) for Cancer Therapy.
Johari B; Moradi M
Methods Mol Biol; 2022; 2521():207-230. PubMed ID: 35733000
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous targeted inhibition of Sox2-Oct4 transcription factors using decoy oligodeoxynucleotides to repress stemness properties in mouse embryonic stem cells.
Johari B; Zargan J
Cell Biol Int; 2017 Dec; 41(12):1335-1344. PubMed ID: 28833847
[TBL] [Abstract][Full Text] [Related]
3. Role of Oct4-Sox2 complex decoy oligodeoxynucleotides strategy on reverse epithelial to mesenchymal transition (EMT) induction in HT29-ShE encompassing enriched cancer stem-like cells.
Bigdelou Z; Mortazavi Y; Saltanatpour Z; Asadi Z; Kadivar M; Johari B
Mol Biol Rep; 2020 Mar; 47(3):1859-1869. PubMed ID: 32016633
[TBL] [Abstract][Full Text] [Related]
4. Increasing the colon cancer cells sensitivity toward radiation therapy via application of Oct4-Sox2 complex decoy oligodeoxynucleotides.
Johari B; Rezaeejam H; Moradi M; Taghipour Z; Saltanatpour Z; Mortazavi Y; Nasehi L
Mol Biol Rep; 2020 Sep; 47(9):6793-6805. PubMed ID: 32865703
[TBL] [Abstract][Full Text] [Related]
5. Investigation of specific binding of designed oligodeoxynucleotide decoys to transcription factors in HT29 cell line undergoing epithelial-mesenchymal transition (EMT).
Bigdelou Z; Johari B; Kadivar M; Rismani E; Asadi Z; Rahmati M; Saltanatpour Z
J Cell Physiol; 2019 Dec; 234(12):22765-22774. PubMed ID: 31115051
[TBL] [Abstract][Full Text] [Related]
6. Application of decoy oligodeoxynucleotides strategy for inhibition of cell growth and reduction of metastatic properties in nonresistant and erlotinib-resistant SW480 cell line.
Asadi Z; Fathi M; Rismani E; Bigdelou Z; Johari B
Cell Biol Int; 2021 May; 45(5):1001-1014. PubMed ID: 33377576
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of decoy oligodeoxynucleotides targeted to NF-kappaB in vitro and in vivo.
Wang T; Li QH; Hao GP; Zhai J
Asian Pac J Cancer Prev; 2010; 11(1):193-200. PubMed ID: 20593956
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of NF-kB decoy oligodeoxynucleotides in a prostate cancer cell line.
Fang Y; Sun H; Zhai J; Zhang Y; Yi S; Hao G; Wang T
Asian Pac J Cancer Prev; 2011; 12(10):2721-6. PubMed ID: 22320981
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of STAT3 decoy oligodeoxynucleotides' synergistic effects on radiation and/or chemotherapy in metastatic breast cancer cell line.
Johari B; Rahmati M; Nasehi L; Mortazavi Y; Faghfoori MH; Rezaeejam H
Cell Biol Int; 2020 Dec; 44(12):2499-2511. PubMed ID: 32841450
[TBL] [Abstract][Full Text] [Related]
10. Suppressing the metastatic properties of the breast cancer cells using STAT3 decoy oligodeoxynucleotides: A promising approach for eradication of cancer cells by differentiation therapy.
Rahmati M; Johari B; Kadivar M; Rismani E; Mortazavi Y
J Cell Physiol; 2020 Jun; 235(6):5429-5444. PubMed ID: 31912904
[TBL] [Abstract][Full Text] [Related]
11. STAT3/NF‑κB decoy oligodeoxynucleotides inhibit atherosclerosis through regulation of the STAT/NF‑κB signaling pathway in a mouse model of atherosclerosis.
An HJ; Gwon MG; Gu H; Bae S; Leem J; Lee JB; Park KK
Int J Mol Med; 2023 May; 51(5):. PubMed ID: 37026512
[TBL] [Abstract][Full Text] [Related]
12. [An experimental study of inhibiting effect of decoy oligodeoxynucleotides on the gene expression of collagen in NIH3T3 cell].
Hao TZ; Liang HP; Lv FL; Xu X; Guo H; Wang FL; Yang WJ; Luo Y; Li L
Zhonghua Shao Shang Za Zhi; 2003 Jun; 19(3):175-8. PubMed ID: 12921625
[TBL] [Abstract][Full Text] [Related]
13. Regulation of NF-kappaB signaling by decoy oligodeoxynucleotides.
Isomura I; Morita A
Microbiol Immunol; 2006; 50(8):559-63. PubMed ID: 16924140
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of STAT3 decoy oligodeoxynucleotides on human epithelial ovarian cancer cell growth in vivo.
Zhang X; Liu P; Zhang B; Mao H; Shen L; Ma Y
Int J Mol Med; 2013 Sep; 32(3):623-8. PubMed ID: 23828376
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of transcription factor T-cell factor 3 (TCF3) using the oligodeoxynucleotide strategy increases embryonic stem cell stemness: possible application in regenerative medicine.
Johari B; Asadi Z; Rismani E; Maghsood F; Sheikh Rezaei Z; Farahani S; Madanchi H; Kadivar M
Cell Biol Int; 2019 Aug; 43(8):852-862. PubMed ID: 31033094
[TBL] [Abstract][Full Text] [Related]
16. Anti-oxidant gene therapy by NF kappa B decoy oligodeoxynucleotide.
Nakagami H; Tomita N; Kaneda Y; Ogihara T; Morishita R
Curr Pharm Biotechnol; 2006 Apr; 7(2):95-100. PubMed ID: 16724943
[TBL] [Abstract][Full Text] [Related]
17. Myc Decoy Oligodeoxynucleotide Inhibits Growth and Modulates Differentiation of Mouse Embryonic Stem Cells as a Model of Cancer Stem Cells.
Johari B; Ebrahimi-Rad M; Maghsood F; Lotfinia M; Saltanatpouri Z; Teimoori-Toolabi L; Sharifzadeh Z; Karimipoor M; Kadivar M
Anticancer Agents Med Chem; 2017; 17(13):1786-1795. PubMed ID: 28403778
[TBL] [Abstract][Full Text] [Related]
18. Effect of Stathmin decoy-oligodeoxynucleotides on the proliferation and differentiation of precartilainous stem cells.
Guo F; Zhang Y; Chen A
J Huazhong Univ Sci Technolog Med Sci; 2007 Oct; 27(5):557-60. PubMed ID: 18060635
[TBL] [Abstract][Full Text] [Related]
19. Suppression of mesangial cell proliferation and extracellular matrix production in streptozotocin-induced diabetic rats by Sp1 decoy oligodeoxynucleotide in vitro and in vivo.
Kang JH; Chae YM; Park KK; Kim CH; Lee IS; Chang YC
J Cell Biochem; 2008 Feb; 103(2):663-74. PubMed ID: 17557290
[TBL] [Abstract][Full Text] [Related]
20. Modeling the therapeutic efficacy of NFκB synthetic decoy oligodeoxynucleotides (ODNs).
Wang Z; Potoyan DA; Wolynes PG
BMC Syst Biol; 2018 Jan; 12(1):4. PubMed ID: 29382384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
